IP Library › Assignment 053349/0990
Patent Assignment
Reel/Frame 053349/0990

Change of Name

Recorded: 2020-07-29 Pages: 6
Assignor
BRIDGENT BIOTECHNOLOGY INC.
Executed: 2020-04-15
Assignee
CALGENT BIOTECHNOLOGY CO., LTD.
24F., NO. 1, SONGZHI RD., XINYI DIST., TAIPEI CITY, 110, TAIWAN
Covered Properties (3)
Aminonaphthoquinone Compounds for Treatment and/or Prevention of Fibrosis Diseases
Application: 15/776,698 →
Publication: US 2018/0325845
Compounds and Pharmaceutical Composition Associated with Ubiquitination-Proteasome System
Application: 15/748,827 →
Publication: US 2019/0144383
Aminonapthoquinone Compounds and Pharmaceutical Composition for Blocking Ubiquitination-Proteasome System in Diseases
Application: 15/746,964 →
Publication: US 2018/0319749
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Nunc Pro Tunc Assignment Jan 29, 2019
From: YEN, YUN; LIOU, JING-PING; PAN, SHIOW-LIN
To: TAIPEI MEDICAL UNIVERSITY
Reel/Frame 048165/0481 →
Assignment of Assignor's Interest Feb 21, 2019
From: YEN, YUN; LIOU, JING-PING; LIN, CHIEN HUANG
To: TAIPEI MEDICAL UNIVERSITY
Reel/Frame 048396/0302 →
Assignment of Assignor's Interest Feb 25, 2019
From: YEN, YUN
To: TAIPEI MEDICAL UNIVERSITY
Reel/Frame 048430/0842 →
Assignment of Assignor's Interest Jan 31, 2020
From: TAIPEI MEDICAL UNIVERSITY
To: BRIDGENT BIOTECHNOLOGY INC.
Reel/Frame 051679/0942 →